Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Specenier · SciRah

Researcher profile · Semantic Scholar

P. Specenier

Share profile

P. Specenier — researcher profile on SciRah

h-index: 29
Works: 159
Citations: 3,242

Most-cited papers

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.
A. Brandes, A. Carpentier, S. Kesari, J. Sepúlveda-Sánchez +15 more
2016Neuro-Oncology249 citations Open access
Semantic Scholar
Programmed Cell Death-1 Inhibitor–Induced Type 1 Diabetes Mellitus
Katrien Clotman, K. Janssens, P. Specenier, I. Weets +1 more
2018Journal of Clinical Endocrinology and Metabolism214 citations Open access
Semantic Scholar
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
A. Ho, I. Braña, R. Haddad, J. Bauman +22 more
2021Journal of Clinical Oncology158 citations Open access
Semantic Scholar
Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor
J. Van den Bossche, F. Lardon, V. Deschoolmeester, I. De Pauw +5 more
2016Medicinal research reviews (Print)104 citations
Semantic Scholar
Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins.
Carolien Boeckx, Ken Op de Beeck, A. Wouters, V. Deschoolmeester +9 more
2014Cancer Letters63 citations
Semantic Scholar
Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium
C. Kenis, L. Decoster, J. Flamaing, P. Debruyne +23 more
2018Annals of Oncology56 citations Open access
Semantic Scholar
Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study
Katherine J. Taylor, C. D. Amdal, K. Bjordal, G. Astrup +32 more
2024International Journal of Cancer51 citations Open access
Semantic Scholar
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
R. Galot, C. le Tourneau, E. Saâda-Bouzid, A. Daste +21 more
2021European Journal of Cancer51 citations Open access
Semantic Scholar
Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma
P. Specenier, J. Vermorken
2018Expert Review of Anticancer Therapy42 citations
Semantic Scholar
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response
Carolien Boeckx, Christine Weyn, Isabelle Vanden Bempt, V. Deschoolmeester +10 more
2014BMC Research Notes42 citations Open access
Semantic Scholar
Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5‐fluorouracil or carboplatin/paclitaxel for first‐line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck
A. Jimeno, J. Machiels, L. Wirth, P. Specenier +9 more
2016Cancer39 citations Open access
Semantic Scholar
Quality of life in oropharyngeal cancer: a structured review of the literature
E. Roets, Karina Tukanova, Anouk Govarts, P. Specenier
2018Supportive Care in Cancer36 citations
Semantic Scholar
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Z. Berneman, M. De Laere, Paul Germonpré, Manon Huizing +31 more
2025Journal of Hematology & Oncology35 citations Open access
Semantic Scholar
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
J. Machiels, P. Specenier, J. Krauss, Andreas Dietz +10 more
2015Cancer Chemotherapy and Pharmacology33 citations
Semantic Scholar
A Literature Review of the Potential Diagnostic Biomarkers of Head and Neck Neoplasms
Heleen Konings, S. Stappers, M. Geens, B. De Winter +5 more
2020Frontiers in Oncology32 citations Open access
Semantic Scholar
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
D. Capper, A. von Deimling, A. Brandes, A. Carpentier +17 more
2017International Journal of Molecular Sciences32 citations Open access
Semantic Scholar
A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators
C. Kenis, P. Heeren, L. Decoster, K. Van Puyvelde +27 more
2015The Journal of Nutrition, Health & Aging32 citations Open access
Semantic Scholar
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study
C. Kenis, L. Decoster, J. Flamaing, P. Debruyne +16 more
2022BMC Geriatrics31 citations Open access
Semantic Scholar
Study protocol for a randomized controlled trial: tongue strengthening exercises in head and neck cancer patients, does exercise load matter?
G. Van Nuffelen, Leen Van den Steen, O. Vanderveken, P. Specenier +8 more
2015Trials30 citations Open access
Semantic Scholar
Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery
C. Quinten, C. Kenis, L. Decoster, P. Debruyne +24 more
2018Quality of Life Research29 citations Open access
Semantic Scholar
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.
Carolien Boeckx, L. Blockx, K. O. de Beeck, Ridha Limame +7 more
2015American Journal of Cancer Research28 citations
Semantic Scholar
In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53
J. Van den Bossche, C. Deben, I. De Pauw, H. Lambrechts +9 more
2019Molecular Oncology26 citations Open access
Semantic Scholar
A phase I study of volasertib combined with afatinib, in advanced solid tumors
J. Machiels, M. Peeters, C. Herremans, V. Surmont +6 more
2015Cancer Chemotherapy and Pharmacology26 citations Open access
Semantic Scholar
Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)
Margot Baudelet, Leen Van den Steen, F. Duprez, M. De Bodt +18 more
2020Trials24 citations Open access
Semantic Scholar
Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors.
Elke Lodewijckx, C. Kenis, J. Flamaing, P. Debruyne +23 more
2020Journal of Geriatric Oncology24 citations Open access
Semantic Scholar
Health related quality of life in older patients with solid tumors and prognostic factors for decline.
L. Decoster, C. Quinten, C. Kenis, J. Flamaing +24 more
2019Journal of Geriatric Oncology23 citations Open access
Semantic Scholar
Evolution of self‐perceived swallowing function, tongue strength and swallow‐related quality of life during radiotherapy in head and neck cancer patients
Leen Van den Steen, D. Van Gestel, O. Vanderveken, J. Vanderwegen +20 more
2019Head and Neck21 citations Open access
Semantic Scholar
Nivolumab in melanoma
P. Specenier
2016Expert Review of Anticancer Therapy21 citations Open access
Semantic Scholar
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
O. Vanderveken, P. Szturz, P. Specenier, M. Merlano +7 more
2016The Oncologist19 citations Open access
Semantic Scholar
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial
P. Specenier, É. Remenár, Jan Buter, Dirk Schrijvers +7 more
2017Annals of Oncology18 citations Open access
Semantic Scholar
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Glen Meert, C. Kenis, K. Milisen, P. Debruyne +16 more
2022Journal of Geriatric Oncology17 citations Open access
Semantic Scholar
Toxicities in long‐term survivors of head and neck cancer—A multi‐national cross‐sectional analysis
Katherine J. Taylor, C. D. Amdal, Kristin Bjordal, G. Astrup +33 more
2025International Journal of Cancer16 citations Open access
Semantic Scholar
Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status
J. Van den Bossche, A. Domen, M. Peeters, C. Deben +8 more
2019Cancers16 citations Open access
Semantic Scholar
Afatinib in squamous cell carcinoma of the head and neck
P. Specenier, J. Vermorken
2016Expert Opinion on Pharmacotherapy16 citations
Semantic Scholar
Incorporating Anti-VEGF Pathway Therapy as a Continuum of Care in Metastatic Colorectal Cancer
K. Papadimitriou, C. Rolfo, E. Dewaele, M. van de Wiel +5 more
2015Current Treatment Options in Oncology15 citations
Semantic Scholar
Immunotherapy for head and neck cancer: from recurrent/metastatic disease to (neo)adjuvant treatment in surgically resectable tumors
P. Specenier
2021Current Opinion in Otolaryngology & Head and Neck Surgery14 citations Open access
Semantic Scholar
Pembrolizumab use for the treatment of advanced melanoma
P. Specenier
2017Expert Opinion on Biological Therapy13 citations
Semantic Scholar
Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma
J. Duerinck, P. Clement, F. Bouttens, C. Andre +13 more
2015Journal of Neurology13 citations
Semantic Scholar
Feasibility of tongue strength measurements during (chemo)radiotherapy in head and neck cancer patients
Leen Van den Steen, O. Vanderveken, J. Vanderwegen, D. Van Gestel +19 more
2017Supportive Care in Cancer12 citations
Semantic Scholar
Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study
Nils Helsen, T. Van den Wyngaert, L. Carp, R. de Bree +21 more
2020European Journal of Nuclear Medicine and Molecular Imaging10 citations Open access
Semantic Scholar
An overview of binimetinib for the treatment of melanoma
P. Specenier
2020Expert Opinion on Pharmacotherapy10 citations
Semantic Scholar
A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R. Galot, C. le Tourneau, E. Saada-Bouzid, A. Daste +16 more
2019Annals of Oncology10 citations Open access
Semantic Scholar
The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥ 70 years) patients with different cancer tumors.
C. Quinten, C. Kenis, L. Decoster, P. Debruyne +24 more
2020Journal of Geriatric Oncology9 citations Open access
Semantic Scholar
EORTC 24051: Unexpected side effects of a phase I study of TPF induction chemotherapy (IC) followed by chemoradiation (CRT) with lapatinib (LAP), a dual EGFR/ErbB2 inhibitor, in patients with locally advanced larynx and hypopharynx squamous cell carcinoma (LA-LxHxSCC).
P. Specenier, Yassine Lalami, J. Vermorken, D. Lacombe +3 more
2016Journal of Clinical Oncology9 citations
Semantic Scholar
Matrix Metalloproteinases in Head and Neck Cancer
P. Specenier, Anja Brouwer
20159 citations
Semantic Scholar
Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy
M. Geens, S. Stappers, Heleen Konings, B. De Winter +9 more
2021PLoS ONE8 citations Open access
Semantic Scholar
Efficacy of nab-paclitaxel in treating metastatic melanoma
P. Specenier
2019Expert Opinion on Pharmacotherapy8 citations
Semantic Scholar
Abstract PR08: Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations
A. Ho, I. Braña, R. Haddad, J. Bauman +22 more
2019Clinical Trials7 citations
Semantic Scholar
Nivolumab in squamous cell carcinoma of the head and neck
P. Specenier
2018Expert Review of Anticancer Therapy7 citations
Semantic Scholar
A phase II study of galunisertib monotherapy or galunisertib plus lomustine compared to lomustine monotherapy in recurrent glioblastoma.
A. Brandes, A. Carpentier, S. Kesari, J. Sepúlveda +12 more
20157 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Peeters×14
Invite
M. Peeters — researcher profile on SciRah
J. Vermorken×12
Invite
J. Vermorken — researcher profile on SciRah
P. Debruyne×10
Invite
P. Debruyne — researcher profile on SciRah
C. Kenis×8
Invite
C. Kenis — researcher profile on SciRah

×8

Invite

L. Decoster — researcher profile on SciRah

Invite

J. Flamaing — researcher profile on SciRah

F. Cornélis×8

Invite

F. Cornélis — researcher profile on SciRah

V. Verschaeve×8

Invite

V. Verschaeve — researcher profile on SciRah

C. Langenaeken×8

Invite

C. Langenaeken — researcher profile on SciRah

Invite

J. Praet — researcher profile on SciRah

O. Vanderveken×8

Invite

O. Vanderveken — researcher profile on SciRah

Invite

I. De Groof — researcher profile on SciRah